- Home
- FPI vs FDMT Comparison
FPI vs FDMT Comparison
Compare FPI & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FPI | FDMT |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.2M | 513.6M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FPI | FDMT |
|---|---|---|
| Price | $11.59 | $8.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $32.40 |
| AVG Volume (30 Days) | ★ 749.6K | 674.7K |
| Earning Date | 05-20-2026 | 04-13-2026 |
| Dividend Yield | ★ 3.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $52,178,000.00 | $37,000.00 |
| Revenue This Year | N/A | $21,227.03 |
| Revenue Next Year | $10.62 | $161.87 |
| P/E Ratio | $19.62 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.37 | $2.24 |
| 52 Week High | $13.23 | $12.34 |
Technical Indicators
Market Signals| Indicator | FPI | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 39.66 | 42.07 |
| Support Level | $11.22 | $8.15 |
| Resistance Level | $11.70 | $8.80 |
| Average True Range (ATR) | 0.36 | 0.55 |
| MACD | -0.17 | -0.12 |
| Stochastic Oscillator | 0.30 | 7.86 |
Price Performance
Historical ComparisonAbout FPI Farmland Partners Inc.
Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.